Public-private partnership as a factor in the development of the pharmaceutical industry economy of the Republic of Kazakhstan

Authors

  • Nurlyaiim Issatayeva Asfendiyarov Kazakh National Medical University, Kazakhstan
  • Ubaidilla Datkhayev
  • Gulmira Datkayeva
  • Raissa Abdullabekova
  • Kairat Zhakipbekov

DOI:

https://doi.org/10.15587/2519-4852.2024.285773

Keywords:

pharmacy, industry development, public administration, business economics, project management, finance

Abstract

The aim. Public-private partnership is a qualitative method of accelerating the growth rate of the country's economy and its individual components. However, it is also important to skillfully apply the features of this method, assessing the peculiarities of the functioning of a particular country or sector. This makes it relevant to consider the specifics of public-private partnerships in the Republic of Kazakhstan and, in particular, in the pharmaceutical industry. Thus, the main purpose of the study was to assess the peculiarities of the development of the pharmaceutical industry of the Republic of Kazakhstan and the impact of public-private partnerships on it. This includes understanding the role public-private partnerships play in enhancing the efficiency and innovation of the industry.

Materials and methods. This study focuses specifically on the Republic of Kazakhstan, as the public-private partnership model varies significantly across countries. The main methods used were analysis, historical method, deduction, and modelling. The specific legislative framework, local economic conditions, and the unique challenges of Kazakhstan's pharmaceutical sector were considered to provide relevant insights.

Results. The authors showed that this area is actively developing; every year, many projects are implemented in various sectors of the economy with the help of this type of interaction. Certain results are also observed in the healthcare industry, which borders the pharmaceutical industry. However, in the context of the production of medicines or the latest technologies, there are certain problems. This industry receives insufficient investment, which is why it does not have the opportunity to develop effectively. This indicates the urgency of more decisive state intervention, including through the use of public-private partnerships. In addition, the study describes some projects that have already been implemented in Kazakhstan and shows the benefits that the state has achieved from their implementation.

Conclusions. The paper brings new knowledge in the context of the investigation of public-private partnership as a method of increasing the efficiency of the functioning of the economy as a whole, and also allows for a better understanding of some features of the development of the Republic of Kazakhstan as a whole and its pharmaceutical industry in particular

References

  1. United Nations Millennium Declaration (2000). Available at: https://www.un.org/ru/documents/decl_conv/declarations/summitdecl.shtml
  2. Monterrey Consensus of the International Conference on Financing for Development (2002). Available at: https://www.un.org/ru/documents/decl_conv/declarations/monterrey.shtml
  3. Uskelenova, A., Filimonova, Y., Zhanbyrbayeva, S., Zhakypbek, L., Dossymova, O. (2022). Stages and features of the implementation of public-private partnership in Kazakhstan. Public Policy and Administration, 21 (5), 556–568.
  4. Kablaev, A., Dauletkalieva, Z., Kalieva, S. (2022). Availability of Free Drug Provision for Patients with Type 2 Diabetes at the Outpatient Level in the Republic of Kazakhstan. Journal of Health Development, 46 (2), 4–12. https://doi.org/10.32921/2225-9929-2022-2-46-4-12
  5. Verweij, S., van Meerkerk, I. (2020). Do public–private partnerships achieve better time and cost performance than regular contracts? Public Money & Management, 41 (4), 286–295. https://doi.org/10.1080/09540962.2020.1752011
  6. Baxter, D., Casady, C. B. (2020). Proactive and Strategic Healthcare Public-Private Partnerships (PPPs) in the Coronavirus (Covid-19) Epoch. Sustainability, 12 (12), 5097. https://doi.org/10.3390/su12125097
  7. Nyurlikhina, G., Salimbayeva, R., Oralbayeva, Zh., Beknazarov, B., Nurgaziyev, K. (2019). Public-private partnership in Kazakhstan: Problems and prospects. Reports of the National Academy of sciences of the Republic of Kazakhstan, 6 (328), 126–135. https://doi.org/10.32014/2019.2518-1483.178
  8. Mouraviev, N. (2021). Rapid Public-Private Partnership Deployment in Kazakhstan: Enablers and Implications. NISPAcee Journal of Public Administration and Policy, 14 (2), 189–221. https://doi.org/10.2478/nispa-2021-0020
  9. About the Concession (2006). Law of the Republic of Kazakhstan No. 167-III. 07.08.2006. Available at: https://online.zakon.kz/Document/?doc_id=30062571
  10. On Public-Private Partnership (2015). Law of the Republic of Kazakhstan No. 379-V. 31.10.2015. Available at: https://online.zakon.kz/Document/?doc_id=37704720
  11. International PPP Standards. UNECE. Available at: https://unece.org/ppp/icoe/standards
  12. Public-private partnerships in developing countries (2013). OIB Study. Hague: Ministry of Foreign Affairs of the Netherlands.
  13. Public-private partnership monitor Kazakhstan (2022). Asian Development Bank. Available at: https://www.adb.org/sites/default/files/publication/850386/public-private-partnership-monitor-kazakhstan.pdf
  14. SK-Pharmacy. Available at: https://sk-pharmacy.kz/eng/
  15. Samruk-Kazyna. Available at: https://sk.kz/?lang=ru
  16. Strides. Available at: https://strides.com/
  17. Kazakhstan Centre for Public-Private Partnership. Available at: https://ppp-center.kz/center-gchp#rec401220749
  18. KPPPC. Available at: https://kzppp.kz/en/p/
  19. Roehrich, J. K., Lewis, M. A., George, G. (2014). Are public–private partnerships a healthy option? A systematic literature review. Social Science & Medicine, 113, 110–119. https://doi.org/10.1016/j.socscimed.2014.03.037
  20. Okoro, R. N., Muhammad, H. M., Jamiu, M. O. (2021). Assessment of public hospital drug supply financing through the public-private partnership: pharmacists’ perspectives. Brazilian Journal of Pharmaceutical Sciences, 57. https://doi.org/10.1590/s2175-97902020000419164
  21. Joudyian, N., Doshmangir, L., Mahdavi, M., Tabrizi, J. S., Gordeev, V. S. (2021). Public-private partnerships in primary health care: a scoping review. BMC Health Services Research, 21 (1). https://doi.org/10.1186/s12913-020-05979-9
  22. Carbonara, N., Pellegrino, R. (2019). The role of public private partnerships in fostering innovation. Construction Management and Economics, 38 (2), 140–156. https://doi.org/10.1080/01446193.2019.1610184
  23. An additional 6 PET centers will be opened in Kazakhstan (2019). Pharmnews. Available at: https://pharmnewskz.com/ru/news/v-kazahstane-budut-otkryty-dopolnitelnye-6-pet-centrov_14958
  24. In 2023, a new Comprehensive Cancer Control Plan will be developed (2023). Pharm reviews. Available at: https://pharm.reviews/novosti/novosti-kazakhstana/item/8096-v-2023-godu-budet-razrabotan-novyj-kompleksnyj-plan-po-borbe-s-onkozabolevaniyami
  25. Badaev, M. (2021). Public-private partnership in healthcare and pharmaceutical sector of the Republic of Kazakhstan. Scientific Bulletin of Mukachevo State University Series “Economics,” 8 (2), 45–55. https://doi.org/10.52566/msu-econ.8(2).2021.45-55
  26. Du, Z. (2018). A Literature Review on Institutional Environment and Technological Innovation. American Journal of Industrial and Business Management, 8 (9), 1941–1950. https://doi.org/10.4236/ajibm.2018.89130
  27. Lebid, O. (2021). E-governance of the economy of the future: world experience and prospects of Ukraine. Ekonomika APK, 324 (10), 98–110. https://doi.org/10.32317/2221-1055.202110098
  28. Ali, Z., Irfan, S., Salman, Y. (2020). Effectiveness of Public Private Partnerships: A Systematic Literature Review. Journal of Management and Research, 7 (2), 104–145. https://doi.org/10.29145/jmr/72/070204
  29. Bao, F., Chan, A. P. C., Chen, C., Darko, A. (2018). Review of Public–Private Partnership Literature from a Project Lifecycle Perspective. Journal of Infrastructure Systems, 24 (3). https://doi.org/10.1061/(asce)is.1943-555x.0000424
  30. Bhuiyan, S. H. (2010). A crisis in governance: Urban solid waste management in Bangladesh. Habitat International, 34 (1), 125–133. https://doi.org/10.1016/j.habitatint.2009.08.002
  31. de Vrueh, R. L. A., Crommelin, D. J. A. (2017). Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact. Pharmaceutical Research, 34 (10), 1985–1999. https://doi.org/10.1007/s11095-017-2192-5
  32. Babenko, K. Y. (2020). Management of territorial economic development: Project approach. Scientific Bulletin of Mukachevo State University. Series “Economics”, 7 (1) 135–140. https://doi.org/10.31339/2313-8114-2020-1(13)-135-140
  33. Davis, A. M., Engkvist, O., Fairclough, R. J., Feierberg, I., Freeman, A., Iyer, P. (2021). Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development. SLAS Discovery, 26 (5), 604–619. https://doi.org/10.1177/2472555220982268
  34. Oseni, Y. O., Afolabi, O. (2014). Comparative analysis of drug revolving fund (DRF) and public private partnership (PPP) program on drug supply management in University college hospital (UCH), Ibadan, Nigeria. West African Journal of Pharmacy, 25 (2), 76–87. https://doi.org/10.60787/wapcp-25-2-55
  35. Sadykova, Z. B. (2021). Public-Private Partnership in Conditions of Innovative Development of the Republic of Kazakhstan. Public Policy and Administration, 20 (3), 464–473. https://doi.org/10.5755/j01.ppaa.20.3.28345
  36. de Vrueh, R. L. A., de Vlieger, J. S. B., Crommelin, D. J. A. (2019). Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare. Frontiers in Medicine, 6. https://doi.org/10.3389/fmed.2019.00114
  37. Zadorozhniuk, N., Malysh, I., Minieieva, I. (2020). Specifics of marketing of pharmaceutical industry. Scientific Bulletin of Mukachevo State University. Series “Economics,” 1 (13), 86–91. https://doi.org/10.31339/2313-8114-2020-1(13)-86-91
Public-private partnership as a factor in the development of the pharmaceutical industry economy of the Republic of Kazakhstan

Downloads

Published

2024-10-31

How to Cite

Issatayeva, N., Datkhayev, U. ., Datkayeva, G. ., Abdullabekova, R. ., & Zhakipbekov, K. . (2024). Public-private partnership as a factor in the development of the pharmaceutical industry economy of the Republic of Kazakhstan. ScienceRise: Pharmaceutical Science, (5 (51), 96–103. https://doi.org/10.15587/2519-4852.2024.285773

Issue

No. 5 (51) (2024)

Section

Pharmaceutical Science

License

Copyright (c) 2024 Nurlyaiim Issatayeva, Ubaidilla Datkhayev, Gulmira Datkayeva, Raissa Abdullabekova, Kairat Zhakipbekov

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.